138 related articles for article (PubMed ID: 6824340)
1. Synthesis and accumulation of an extremely stable high-energy phosphate compound by muscle, heart, and brain of animals fed the creatine analog, 1-carboxyethyl-2-iminoimidazolidine (homocyclocreatine).
Roberts JJ; Walker JB
Arch Biochem Biophys; 1983 Feb; 220(2):563-71. PubMed ID: 6824340
[TBL] [Abstract][Full Text] [Related]
2. Relative abilities of phosphagens with different thermodynamic or kinetic properties to help sustain ATP and total adenylate pools in heart during ischemia.
Turner DM; Walker JB
Arch Biochem Biophys; 1985 May; 238(2):642-51. PubMed ID: 3994395
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of analgo of phosphocreatine in muscle of chicks fed 1-carboxymethyl-2-iminoimidazolidine (cyclocreatine).
Griffiths GR; Walker JB
J Biol Chem; 1976 Apr; 251(7):2049-54. PubMed ID: 1270421
[TBL] [Abstract][Full Text] [Related]
4. Higher homolog and N-ethyl analog of creatine as synthetic phosphagen precursors in brain, heart, and muscle, repressors of liver amidinotransferase, and substrates for creatine catabolic enzymes.
Roberts JJ; Walker JB
J Biol Chem; 1985 Nov; 260(25):13502-8. PubMed ID: 4055745
[TBL] [Abstract][Full Text] [Related]
5. Enhanced ability of skeletal muscle containing cyclocreatine phosphate to sustain ATP levels during ischemia following beta-adrenergic stimulation.
Turner DM; Walker JB
J Biol Chem; 1987 May; 262(14):6605-9. PubMed ID: 3571272
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of creatine analogues as a new class of anticancer agents using freshly explanted human tumor cells.
Martin KJ; Chen SF; Clark GM; Degen D; Wajima M; Von Hoff DD; Kaddurah-Daouk R
J Natl Cancer Inst; 1994 Apr; 86(8):608-13. PubMed ID: 8145276
[TBL] [Abstract][Full Text] [Related]
7. Myocardial protection during ischemia by prior feeding with the creatine analog: cyclocreatine.
Jacobstein MD; Gerken TA; Bhat AM; Carlier PG
J Am Coll Cardiol; 1989 Jul; 14(1):246-51. PubMed ID: 2738267
[TBL] [Abstract][Full Text] [Related]
8. Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors.
Lillie JW; O'Keefe M; Valinski H; Hamlin HA; Varban ML; Kaddurah-Daouk R
Cancer Res; 1993 Jul; 53(13):3172-8. PubMed ID: 8319226
[TBL] [Abstract][Full Text] [Related]
9. Creatine kinase kinetics, ATP turnover, and cardiac performance in hearts depleted of creatine with the substrate analogue beta-guanidinopropionic acid.
Shoubridge EA; Jeffry FM; Keogh JM; Radda GK; Seymour AM
Biochim Biophys Acta; 1985 Oct; 847(1):25-32. PubMed ID: 4052460
[TBL] [Abstract][Full Text] [Related]
10. Creatine and cyclocreatine effects on ischemic myocardium: 31P nuclear magnetic resonance evaluation of intact heart.
Osbakken M; Ito K; Zhang D; Ponomarenko I; Ivanics T; Jahngen EG; Cohn M
Cardiology; 1992; 80(3-4):184-95. PubMed ID: 1511465
[TBL] [Abstract][Full Text] [Related]
11. Critical role of phosphagens in the energy cascade of cutaneous ischemia and protective action of phosphocreatine analogues in skin flap survival.
Cuono CB; Marquetand R; Klein MB; Armitage I
Plast Reconstr Surg; 1998 May; 101(6):1597-603. PubMed ID: 9583491
[TBL] [Abstract][Full Text] [Related]
12. Energy metabolism of skeletal muscle containing cyclocreatine phosphate. Delay in onset of rigor mortis and decreased glycogenolysis in response to ischemia or epinephrine.
Annesley TM; Walker JB
J Biol Chem; 1980 May; 255(9):3924-30. PubMed ID: 7372660
[No Abstract] [Full Text] [Related]
13. Regulation of energy flux through the creatine kinase reaction in vitro and in perfused rat heart. 31P-NMR studies.
Kupriyanov VV; Ya Steinschneider A; Ruuge EK; Kapel'ko VI; Yu Zueva M; Lakomkin VL; Smirnov VN; Saks VA
Biochim Biophys Acta; 1984 Dec; 805(4):319-31. PubMed ID: 6509089
[TBL] [Abstract][Full Text] [Related]
14. Creatine kinase equilibration follows solution thermodynamics in skeletal muscle. 31P NMR studies using creatine analogs.
Wiseman RW; Kushmerick MJ
J Biol Chem; 1995 May; 270(21):12428-38. PubMed ID: 7759484
[TBL] [Abstract][Full Text] [Related]
15. Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency.
Kurosawa Y; Degrauw TJ; Lindquist DM; Blanco VM; Pyne-Geithman GJ; Daikoku T; Chambers JB; Benoit SC; Clark JF
J Clin Invest; 2012 Aug; 122(8):2837-46. PubMed ID: 22751104
[TBL] [Abstract][Full Text] [Related]
16. Free ADP levels in transgenic mouse liver expressing creatine kinase. Effects of enzyme activity, phosphagen type, and substrate concentration.
Brosnan MJ; Chen L; Van Dyke TA; Koretsky AP
J Biol Chem; 1990 Dec; 265(34):20849-55. PubMed ID: 2249991
[TBL] [Abstract][Full Text] [Related]
17. In vivo brain phosphocreatine and ATP regulation in mice fed a creatine analog.
Holtzman D; Meyers R; O'Gorman E; Khait I; Wallimann T; Allred E; Jensen F
Am J Physiol; 1997 May; 272(5 Pt 1):C1567-77. PubMed ID: 9176148
[TBL] [Abstract][Full Text] [Related]
18. Utilization of the synthetic phosphagen cyclocreatine phosphate by a simple brain model during stimulation by neuroexcitatory amino acids.
Woznicki DT; Walker JB
J Neurochem; 1988 May; 50(5):1640-7. PubMed ID: 2896231
[TBL] [Abstract][Full Text] [Related]
19. High-performance liquid chromatographic assays for free and phosphorylated derivatives of the creatine analogues beta-guanidopropionic acid and 1-carboxy-methyl-2-iminoimidazolidine (cyclocreatine).
Wiseman RW; Moerland TS; Chase PB; Stuppard R; Kushmerick MJ
Anal Biochem; 1992 Aug; 204(2):383-9. PubMed ID: 1443539
[TBL] [Abstract][Full Text] [Related]
20. Role of phosphocreatine in energy transport in skeletal muscle of bullfrog studied by 31P-NMR.
Yoshizaki K; Watari H; Radda GK
Biochim Biophys Acta; 1990 Feb; 1051(2):144-50. PubMed ID: 2310769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
